Babesia Treatment: What Works and Why Doxycycline Doesn’t

Babesia is a tick-borne parasite, not a Lyme bacterium.
Doxycycline may treat Lyme disease but does not adequately treat Babesia.
Persistent symptoms after Lyme treatment may point to a coinfection.

When Lyme disease treatment overlooks Babesia, patients may remain ill. Babesia is an increasingly recognized tick-borne infection. While many patients and clinicians are familiar with Lyme disease, they may not consider coinfections such as Babesia—especially when symptoms persist after Lyme treatment.

This distinction matters because doxycycline is not considered adequate treatment for babesiosis. Doxycycline is commonly used for Lyme disease and several bacterial tick-borne infections, but Babesia is a protozoan parasite that infects red blood cells. Babesia treatment typically requires antiparasitic medication, most often atovaquone combined with azithromycin.

Why Doxycycline Doesn’t Treat Babesia

Doxycycline works against certain bacteria. Lyme disease is caused by Borrelia burgdorferi, a bacterium. Babesiosis, however, is caused by a protozoan parasite that lives inside red blood cells. A patient can therefore receive appropriate Lyme disease antibiotics and remain ill if Babesia is also present.

Doxycycline alone is not a recommended treatment for babesiosis. Medications such as atovaquone combined with azithromycin are used because they target Babesia more directly.

This is one reason Babesia may be missed. A patient may improve partially with doxycycline because the Lyme disease component is being treated, while fatigue, night sweats, air hunger, headaches, chills, dizziness, or brain fog continue if Babesia remains untreated.

Babesia vs. Lyme Disease

Lyme disease	Babesiosis
Bacterial infection	Protozoan parasitic infection
Caused by Borrelia burgdorferi	Often caused by Babesia microti in the United States
May be treated with doxycycline, amoxicillin, or cefuroxime	Typically treated with atovaquone plus azithromycin
May cause an expanding rash, joint pain, facial palsy, or neurologic symptoms	May cause fever, chills, sweats, fatigue, anemia, or shortness of breath
Can involve multiple tissues and organ systems	Infects red blood cells

Case Study 1: Missed Coinfection

I treated a patient who did not improve after a month of doxycycline for Lyme disease. Six months later, she remained ill with persistent fatigue and cognitive difficulties. Further evaluation suggested that the tick bite had also transmitted Babesia—a coinfection that doxycycline alone could not adequately treat.

After beginning Babesia-directed treatment with atovaquone and azithromycin, she improved significantly and eventually recovered. This case illustrates the importance of considering coinfections when symptoms do not resolve with Lyme disease treatment alone.

Case Study 2: Unrecognized Transmission

Another patient unknowingly had Babesia and donated blood. The recipient of the transfusion developed babesiosis. Unlike Lyme disease, Babesia can survive in stored blood and may be transmitted through transfusion.

This represents an important public health concern. Some people do not know they are infected until Babesia is discovered following persistent symptoms, abnormal blood counts, or transmission through donated blood.

Rising Awareness of Babesia

Babesia continues to be an important and expanding tick-borne health concern. The first recognized human case of babesiosis caused by Babesia microti in the United States was reported in 1969 in a person who had vacationed in Massachusetts.

Research by Krause and colleagues found that 24 of 46 untreated individuals had detectable Babesia DNA in their blood for an average of 82 days. These findings demonstrated that infection can persist for months, including in some people with few or no symptoms.

Symptoms That May Suggest Babesia

Babesia symptoms can overlap with Lyme disease and other conditions. Several symptoms and clinical findings may raise concern for babesiosis, particularly when they persist after Lyme disease treatment:

• Night sweats
• Fever or chills
• Air hunger or shortness of breath
• Persistent fatigue
• Headaches
• Dizziness
• Brain fog
• Anemia or other abnormal blood counts
• Dark urine in more severe cases

Not every patient experiences all these findings. Persistent symptoms alone do not establish a Babesia diagnosis and should prompt an individualized clinical evaluation.

Serious Health Risks

Babesiosis can lead to serious complications, including:

• Hemolytic anemia
• Atrial fibrillation and other cardiac complications
• Noncardiogenic pulmonary edema
• Kidney, liver, or other organ dysfunction

Deaths from babesiosis have been reported, including cases in New York State and Nantucket Island. Although many infections are mild, babesiosis can become life-threatening, particularly in older adults, immunocompromised patients, and people without a spleen.

Why Lyme Treatment Fails When Babesia Is Missed

I have treated patients who remained ill until Babesia was identified and addressed. Some had been labeled with Post-Treatment Lyme Disease Syndrome (PTLDS) or told that nothing more could be done.

Some of these patients improved after receiving Babesia-directed treatment. Their experiences reinforce the need to keep Babesia on the differential diagnosis when patients do not respond as expected to Lyme disease treatment.

This does not mean that everyone who remains ill after Lyme treatment has Babesia. Persistent symptoms can have several explanations, including the effects of the original illness, another tick-borne infection, a post-infectious process, medication complications, or an unrelated medical condition.

Why One Medication May Not Treat Every Tick-Borne Infection

Ticks can transmit pathogens from different biological groups. Borrelia burgdorferi, which causes Lyme disease, is a bacterium. Babesia is a protozoan parasite that infects red blood cells. A medication directed at one pathogen may therefore have little or no activity against another.

A 2026 review of emerging and important tick-borne pathogens noted that mixed bacterial and protozoal infections can complicate treatment because a single medication may not cover every pathogen. The authors also emphasized that coinfections can complicate symptoms, diagnosis, treatment, and recovery.

This does not establish a single treatment approach for every coinfected patient. Instead, it reinforces the importance of identifying which pathogens may be involved and selecting treatment based on the individual clinical picture.

Transmission Risks

Babesia is not transmitted only through tick bites. Other recognized routes include:

• Blood transfusion: The parasite can survive in donated blood and be transmitted to a recipient.
• Mother-to-child transmission: Although rare, Babesia can be transmitted during pregnancy or around the time of delivery.

Pregnant women should take precautions to avoid tick exposure and seek prompt medical evaluation when a tick-borne infection is suspected.

What Is the Best Treatment for Babesia?

Babesia treatment commonly involves atovaquone combined with azithromycin. This regimen is generally well tolerated and is commonly preferred for mild to moderate babesiosis.

Clindamycin combined with quinine is another treatment option, although it is often less well tolerated. Patients with severe babesiosis may require hospitalization, intravenous medications, close monitoring, and, in selected cases, exchange transfusion.

For selected patients with relapsing or refractory babesiosis—particularly those who are immunocompromised—tafenoquine has been described as a potential salvage therapy in case reports and small clinical series. However, tafenoquine is not standard first-line therapy and requires careful clinical oversight.

Treatment Failure and Relapse

Some patients, particularly those who are immunocompromised, diagnosed late, or infected with additional tick-borne pathogens, may relapse after standard Babesia treatment. These patients may require a longer course, repeat treatment, or additional evaluation for persistent parasitemia.

Treatment duration depends on disease severity, immune status, clinical response, laboratory findings, and whether parasitemia persists. A single treatment plan is not appropriate for every patient.

Frequently Asked Questions

Does doxycycline treat Babesia?

No. Doxycycline treats certain bacterial infections, including Lyme disease, but it is not considered adequate treatment for babesiosis. Babesia typically requires antiparasitic medications such as atovaquone combined with azithromycin.

Why doesn’t doxycycline kill Babesia?

Doxycycline has activity against certain bacteria, but Babesia is a protozoan parasite that infects red blood cells. A patient may therefore need Babesia-directed treatment even after receiving antibiotics for Lyme disease.

What kills Babesia?

Babesia is treated with antiparasitic medications rather than standard Lyme disease antibiotics. A commonly used regimen combines atovaquone with azithromycin, although severe or relapsing infections may require a different treatment approach.

What is the standard treatment for Babesia?

Standard treatment commonly involves atovaquone combined with azithromycin. Clindamycin combined with quinine is another option but is often less well tolerated. Severe babesiosis may require hospital-based treatment and additional interventions.

Is tafenoquine used for Babesia?

Tafenoquine has been used as a potential salvage option for selected patients with relapsing or refractory babesiosis, particularly those who are immunocompromised. It is not standard first-line therapy and requires careful clinical oversight.

Why can symptoms continue after Lyme treatment?

Symptoms may continue for several reasons, including an unrecognized Babesia coinfection, another tick-borne infection, residual effects of the original illness, a post-infectious process, medication complications, or an unrelated condition. Persistent symptoms warrant an individualized reassessment.

How long does Babesia treatment take?

Treatment duration varies according to disease severity, immune status, clinical response, laboratory findings, and whether parasitemia persists. Immunocompromised patients and those with relapsing infection may require longer treatment and closer monitoring.

Clinical Takeaway

Babesia coinfection is one possible explanation for persistent illness after Lyme disease treatment because doxycycline treats bacterial Lyme disease but does not adequately treat parasitic Babesia.

Clinicians should consider Babesia when patients remain symptomatic after Lyme antibiotics, particularly when symptoms include fatigue, night sweats, fever, chills, air hunger, headaches, dizziness, or brain fog. Babesia also presents public health concerns because it can be transmitted through blood transfusion and, rarely, during pregnancy.

The key clinical point is simple: when Lyme treatment helps only partially—or does not help at all—Babesia should remain on the differential diagnosis.

Related Articles

These related articles explore Babesia symptoms, testing, treatment duration, and relapse concerns.

Babesia Treatment Duration: How Long Is Long Enough?

Babesia Testing: Why Negative Results Don’t Always Mean Negative

Babesia Symptoms: What Patients Should Know

Night Sweats and Babesia: The Symptom Doctors Miss

Babesia Coinfection Makes Lyme Worse

References

1. Krause PJ, Lepore T, Sikand VK, et al. Atovaquone and azithromycin for the treatment of babesiosis. N Engl J Med. 2000;343(20):1454–1458. doi:10.1056/NEJM200011163432004.
2. Krause PJ, Spielman A, Telford SR III, et al. Persistent parasitemia after acute babesiosis. N Engl J Med. 1998;339(3):160–165. doi:10.1056/NEJM199807163390304.
3. Krause PJ, Auwaerter PG, Bannuru RR, et al. Clinical practice guidelines by the Infectious Diseases Society of America: 2020 guideline on diagnosis and management of babesiosis. Clin Infect Dis. 2021;72(2):e49–e64. doi:10.1093/cid/ciaa1216.
4. Duan G, Kong L, Duan S, Nie S, Gu W. Research progress on emerging and important tick-borne pathogens. Front Microbiol. 2026;17:1866307. doi:10.3389/fmicb.2026.1866307.
5. Centers for Disease Control and Prevention. Clinical Overview of Babesiosis. Accessed August 8, 2026.

This article is for informational purposes only and is not a substitute for individualized medical advice, diagnosis, or treatment.

---

Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.

Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention